Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
What Happens This Week Will Lead the Market for 2023
07:41pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
From big tech earnings to employment data and interest rate decisions, this is an extremely significant week for Wall Street
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast
07:36pm, Tuesday, 31'st Jan 2023 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday.
The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P
Markets Close Well into the Green; AMD, SNAP Report Q4
07:17pm, Tuesday, 31'st Jan 2023
The Dow gained +356 points, +1.06%; the S&P 500 reached +1.48%; and the tech-heavy Nasdaq rose +191 points, +1.68% for the session.
Pfizer’s COVID revenues have dropped off along with attention to the pandemic
06:16pm, Tuesday, 31'st Jan 2023 MarketWatch
Wall Street urged Pfizer to lower its COVID revenue estimates. The company did — but it's still betting on higher demand for its vaccine and antiviral by 2025.
Pfizer Can't Catch a Break, but Investors Can
06:10pm, Tuesday, 31'st Jan 2023
Shares of Pfizer Inc. ( PFE , Financial) fell 15% in the month of January, ending the month on a low note with an earnings report that included a lackluster outlook for 2023. Following record revenue
Pfizer Inc. (PFE) Q4 2022 Earnings Call Transcript
04:19pm, Tuesday, 31'st Jan 2023
Pfizer Inc. (NYSE:PFE ) Q4 2022 Results Conference Call January 31, 2023 10:00 AM ET Company Participants Chris Stevo - SVP and Chief IR Officer Dr. Albert Bourla - Chairman and CEO Dave Denton - CFO
What Happens This Week Will Lead the Market for 2023
04:16pm, Tuesday, 31'st Jan 2023
From big tech earnings to employment data and interest rate decisions, this is an extremely significant week for Wall Street
Employment Cost Index Comes in Lowest Since Q4 2021
04:06pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Employment Cost Index Comes in Lowest Since Q4 2021.
Moderna's stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023
01:52pm, Tuesday, 31'st Jan 2023
Moderna Inc.'s MRNA shares were down 2.8% in trading on Tuesday. Pfizer Inc. PFE, which makes a competing COVID-19 vaccine to Moderna's Spikevax, on Tuesday put out guidance for 2023, saying it expect
Pfizer forecasts big drop in revenue after record $100M COVID-led haul
01:44pm, Tuesday, 31'st Jan 2023
Chief Executive Albert Bourla said that 2023 should be a "transition year" for Pfizer's COVID products, before potentially returning to growth in 2024.
Pfizer issues weak guidance despite Q4 earnings beat
12:45pm, Tuesday, 31'st Jan 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss fourth-quarter earnings for Pfizer.
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
12:31pm, Tuesday, 31'st Jan 2023
Pfizer (PFE) beats estimates for Q4 earnings and sales. Its 2023 financial outlook falls short of expectations.
Employment Cost Index Comes in Lowest Since Q4 2021
12:30pm, Tuesday, 31'st Jan 2023
Employment Cost Index Comes in Lowest Since Q4 2021.
Pfizer posts record-breaking 2022 full-year revenue of $100B but expects that to fall by 33% in 2023
11:20am, Tuesday, 31'st Jan 2023
Pfizer Inc (NYSE:PFE) posted record-high revenue of $100.3 billion in 2022, fueled by more than $50 billion in sales of its Covid-19 vaccine and treatments, but the company isn't expecting a repeat of
The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion
10:41am, Tuesday, 31'st Jan 2023
Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.
